05/18/2021

Dr. Bernard A. Fox Appointed the Member of Scientific Advisory Committee of CanWell

CanWell announced today that Dr. Bernard A. Fox is appointed as the Advisor of CanWell’s Scientific Advisory Committee (SAC). Dr. Fox is a leading researcher in the field of cancer…

Read more
03/22/2021

CanWell, Sun Yat-sen Memorial Hospital of Sun Yat-sen University and UbiVac Jointly Held a Clinical Seminar on Cancer Vaccine DPV-001

Sun Yat-sen Memorial Hospital of Sun Yat-sen University, together with CanWell and UbiVac, Inc., successfully held the First-in-Class International Symposium on Clinical Trials of Cancer Vaccine DPV-001 Vaccine. CanWell has…

Read more
02/25/2021

CanWell and UbiVac Announce Exclusive License Agreement For Cancer Vaccine DPV-001 in Greater China

CanWell Pharma Inc., a leading venture-backed biopharmaceutical company developing innovative immunotherapies for cancer, and UbiVac, Inc., a US clinical stage immunotherapy company, today announced an exclusive license agreement to develop and…

Read more